Stifel Financial Corp Purchases 907 Shares of Cardinal Health, Inc. (NYSE:CAH)

Stifel Financial Corp increased its position in Cardinal Health, Inc. (NYSE:CAH) by 0.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 157,562 shares of the company’s stock after purchasing an additional 907 shares during the quarter. Stifel Financial Corp owned approximately 0.07% of Cardinal Health worth $18,635,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. State of Tennessee Department of Treasury boosted its holdings in shares of Cardinal Health by 43.6% during the 4th quarter. State of Tennessee Department of Treasury now owns 194,491 shares of the company’s stock valued at $23,002,000 after buying an additional 59,055 shares in the last quarter. Van Lanschot Kempen Investment Management N.V. lifted its position in Cardinal Health by 1.1% during the 4th quarter. Van Lanschot Kempen Investment Management N.V. now owns 254,605 shares of the company’s stock valued at $30,112,000 after acquiring an additional 2,681 shares during the period. TD Waterhouse Canada Inc. boosted its stake in Cardinal Health by 253.0% during the fourth quarter. TD Waterhouse Canada Inc. now owns 2,358 shares of the company’s stock worth $279,000 after acquiring an additional 1,690 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in Cardinal Health by 40.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 13,342 shares of the company’s stock worth $1,578,000 after purchasing an additional 3,869 shares during the period. Finally, MetLife Investment Management LLC increased its stake in shares of Cardinal Health by 0.7% during the fourth quarter. MetLife Investment Management LLC now owns 70,454 shares of the company’s stock valued at $8,333,000 after purchasing an additional 471 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

NYSE CAH opened at $137.64 on Friday. The business’s fifty day moving average is $130.82 and its 200 day moving average is $123.95. The company has a market capitalization of $33.25 billion, a PE ratio of 25.68, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $139.50.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st were paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Analyst Ratings Changes

CAH has been the topic of several recent research reports. Citigroup upped their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Morgan Stanley increased their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Finally, Bank of America lifted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday, April 11th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $140.86.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.